These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23095714)

  • 1. Different pattern of clinical deficits in stroke mimics treated with intravenous thrombolysis.
    Sarikaya H; Yilmaz M; Luft AR; Gantenbein AR
    Eur Neurol; 2012; 68(6):344-9. PubMed ID: 23095714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features.
    Guillan M; Alonso-Canovas A; Gonzalez-Valcarcel J; Garcia Barragan N; Garcia Caldentey J; Hernandez-Medrano I; Defelipe-Mimbrera A; Sanchez-Gonzalez V; Terecoasa E; Alonso de Leciñana M; Masjuan J
    Cerebrovasc Dis; 2012; 34(2):115-20. PubMed ID: 22854315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of final infarct volumes in patients who received endovascular therapy or intravenous thrombolysis for acute intracranial large-vessel occlusions.
    Rangaraju S; Owada K; Noorian AR; Nogueira RG; Nahab F; Glenn BA; Belagaje SR; Anderson AM; Frankel MR; Gupta R
    JAMA Neurol; 2013 Jul; 70(7):831-6. PubMed ID: 23699864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study.
    Brunser AM; Illanes S; Lavados PM; Muñoz P; Cárcamo D; Hoppe A; Olavarria VV; Delgado I; Díaz V
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1140-5. PubMed ID: 23253534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
    Köhrmann M; Nowe T; Huttner HB; Engelhorn T; Struffert T; Kollmar R; Saake M; Doerfler A; Schwab S; Schellinger PD
    Cerebrovasc Dis; 2009; 27(2):160-6. PubMed ID: 19092237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of good clinical outcome in acute stroke patients treated with intravenous thrombolysis.
    Saňák D; Herzig R; Zapletalová J; Horák D; Král M; Skoloudík D; Bártková A; Veverka T; Heřman M; Kaňovský P
    Acta Neurol Scand; 2011 May; 123(5):339-44. PubMed ID: 20597864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The factors predicting early efficacy of intravenous thrombolysis with alteplase in acute ischemic stroke].
    Song YP; Li YS
    Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):781-3. PubMed ID: 23290976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of telemedicine on acute management of stroke patients undergoing endovascular procedures.
    Pedragosa A; Alvarez-Sabín J; Rubiera M; Rodriguez-Luna D; Maisterra O; Molina C; Brugués J; Ribó M
    Cerebrovasc Dis; 2012; 34(5-6):436-42. PubMed ID: 23207552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience.
    Galldiks N; Zaro-Weber O; Dohmen C; Neveling M; Haupt WF; Fink GR; Sobesky J
    Cerebrovasc Dis; 2010; 30(5):514-8. PubMed ID: 20861623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series.
    Tsivgoulis G; Alexandrov AV; Chang J; Sharma VK; Hoover SL; Lao AY; Liu W; Stamboulis E; Alexandrov AW; Malkoff MD; Frey JL
    Stroke; 2011 Jun; 42(6):1771-4. PubMed ID: 21493900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
    Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
    Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label thrombolysis for acute ischemic stroke: rate, clinical outcome and safety are influenced by the definition of 'minor stroke'.
    Breuer L; Blinzler C; Huttner HB; Kiphuth IC; Schwab S; Köhrmann M
    Cerebrovasc Dis; 2011; 32(2):177-85. PubMed ID: 21849777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after thrombolysis for acute isolated posterior cerebral artery occlusion.
    Meier N; Fischer U; Schroth G; Findling O; Brekenfeld C; El-Koussy M; De Marchis GM; Mono ML; Jung S; Gralla J; Nedeltchev K; Mattle HP; Arnold M
    Cerebrovasc Dis; 2011; 32(1):79-88. PubMed ID: 21677431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of intravenous thrombolysis in stroke mimics: prospective 5-year study and comprehensive meta-analysis.
    Tsivgoulis G; Zand R; Katsanos AH; Goyal N; Uchino K; Chang J; Dardiotis E; Putaala J; Alexandrov AW; Malkoff MD; Alexandrov AV
    Stroke; 2015 May; 46(5):1281-7. PubMed ID: 25791717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after tissue plasminogen activator administration under the drip and ship paradigm may differ according to the regional stroke care system.
    Cha JK; Nah HW; Kang MJ; Kim DH; Park HS; Kim SB; Jeong EH; Huh JT
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):160-3. PubMed ID: 24157090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.